Skip to main content
OpenTrials
Completed

NCT Number: NCT05408286

Post Covid-19 Quality of Life After Hospital Discharge in Patients Treated With NIV/C-PAP

A multicenter longitudinal study with data collection at 4 and 8 months after hospital discharge.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Quality of Life

Age range

18 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Azienda ospedaliera nazionale SS Antonio e Biagio e Cesare Arrigo

Alessandria, 15121, Italy

About this study

The study population consisted of patients treated with NIV/CPAP, admitted to the COVID-19 wards of the AO SS Antonio e Biagio and Cesare Arrigo in Alessandria (the promoting center), the Azienda Sanitaria Locale Bt (Barletta, Andria, Trani) and the Azienda Socio Sanitaria Territoriale in Lecco, from November 2020 to June 2021. The study assessed at 4 and 8 months after hospital discharge in the patient's home environment, quality of life, residual disability, anxiety and insomnia.

Enrollment took place only after the approval of the Ethics Committee of each participating center.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients aged ≥18 years admitted for COVID-19 pneumonia treated with NIV/CPAP, discharged to their home with a negative molecular swab and signed informed consent were included in the study

Exclusion criteria

Exclusion criteria

were set in; patients admitted for COVID-19 pneumonia treated with NIV/CPAP and invasive ventilation and patients with pre-existing cognitive disorders at the hospital admission date.

Treatment and study plan

administration of questionnaires

Behavioral

administration of questionnaires

Primary outcomes

  1. COVID-19 qualità di vita

    Time frame: 8 mesi

    polmonite COVID-19 qualità di vita

Sponsors and collaborators

Lead sponsor

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Other

Registry information

Official study title

Impact of COVID-19 on Quality of Life After Hospital Discharge in Patients Treated With NIV/C-PAP: an Observational, Prospective Multicenter Study.

Acronym: VIDI-CAP

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jun 7, 2022
Registry last updated
Jun 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.